PETTAZZONI, PIERGIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 3.097
EU - Europa 2.188
AS - Asia 1.424
Continente sconosciuto - Info sul continente non disponibili 156
SA - Sud America 142
AF - Africa 42
OC - Oceania 9
Totale 7.058
Nazione #
US - Stati Uniti d'America 2.997
IT - Italia 1.183
SG - Singapore 547
CN - Cina 447
SE - Svezia 192
VN - Vietnam 144
IE - Irlanda 128
FR - Francia 116
BR - Brasile 114
DE - Germania 113
FI - Finlandia 113
GB - Regno Unito 85
KR - Corea 61
CA - Canada 58
UA - Ucraina 56
IN - India 44
AT - Austria 38
PL - Polonia 38
JP - Giappone 37
HK - Hong Kong 34
NL - Olanda 33
DK - Danimarca 27
ID - Indonesia 20
BE - Belgio 18
BD - Bangladesh 13
IQ - Iraq 13
MX - Messico 13
SN - Senegal 12
IR - Iran 10
RU - Federazione Russa 10
TR - Turchia 10
AR - Argentina 9
AU - Australia 8
EG - Egitto 7
TW - Taiwan 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
BY - Bielorussia 6
ES - Italia 6
KE - Kenya 6
CO - Colombia 5
EC - Ecuador 5
JM - Giamaica 5
PK - Pakistan 5
RO - Romania 5
CR - Costa Rica 4
EU - Europa 4
MU - Mauritius 4
NP - Nepal 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
GT - Guatemala 3
IL - Israele 3
MA - Marocco 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
MK - Macedonia 2
PA - Panama 2
PR - Porto Rico 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BT - Bhutan 1
CL - Cile 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GP - Guadalupe 1
HR - Croazia 1
JO - Giordania 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
Totale 6.904
Città #
Singapore 297
Ashburn 276
Chandler 272
Beijing 218
Torino 161
San Jose 157
Fairfield 144
Dublin 128
Houston 116
Santa Clara 108
Ann Arbor 99
Milan 82
Rome 79
Woodbridge 78
Dallas 69
Dearborn 66
Jacksonville 66
Wilmington 63
Nyköping 57
Los Angeles 52
Seattle 51
The Dalles 46
Helsinki 42
Villeurbanne 42
Pisa 41
New York 40
Princeton 39
Cambridge 38
Columbus 38
Ho Chi Minh City 38
Vienna 37
Council Bluffs 33
Munich 33
Medford 31
Hong Kong 30
Redwood City 29
Warsaw 29
Lauterbourg 28
Shanghai 27
Fremont 26
Hanoi 26
Dong Ket 24
Boardman 23
Nanjing 23
Hefei 22
Verona 19
Boston 18
Phoenix 18
Buffalo 17
Florence 17
Brussels 16
Orem 15
Bologna 13
Seoul 13
Tokyo 13
Turku 13
Guangzhou 12
Serra 12
Catania 11
Jakarta 11
Nuremberg 11
Palermo 11
São Paulo 10
Turin 10
Washington 10
Montreal 9
Naples 9
Napoli 8
Auburn Hills 7
Bari 7
Bengaluru 7
Chennai 7
Haiphong 7
Parma 7
Porto Sant'Elpidio 7
San Diego 7
Taipei 7
Toronto 7
Atlanta 6
Chicago 6
Frankfurt am Main 6
Hangzhou 6
Jinan 6
Nairobi 6
Norwalk 6
Ottawa 6
Philadelphia 6
Shenyang 6
Belo Horizonte 5
Changsha 5
Mexico City 5
Mumbai 5
Perugia 5
Stockholm 5
Udine 5
Brescia 4
Brooklyn 4
Capannori 4
Chengdu 4
Erbil 4
Totale 3.905
Nome #
Effetti del 4-idrossinonenale, un’aldeide prodotta dalla perossidazione lipidica, sull’espressione dei microRNA in cellule leucemiche umane HL-60 1.100
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses 472
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. 307
Drug Delivery Nanoparticles in Skin Cancers 306
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 303
Interaction of aldehydes derived from lipid peroxidation and membrane proteins. 265
AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells. 261
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells 260
AS601245, an Anti-Inflammatory JNK Inhibitor, Strengthens the Effects of Clofibrate and Affects Gene Expression Profile, in CaCo-2 Colon Cancer Cells 233
Antitumor activity of nanosponge-encapsulated camptothecin in human prostate tumors 230
Antitumor activity of nanosponge-encapsulated camptotechin in human prostate tumors. 214
PPARy in coronary atherosclerosis: In vivo expression pattern and correlations with hyperlipidemic status and statin treatment 210
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion and migration of colon cancer cells 194
Lipid peroxidation in colorectal carcinogenesis: bad and good news 178
4-Hydroxynonenal (HNE), a product of lipide peroxidation, inhibits telomerase activity in Caco-2, a colon cancer cell line, by the inhibition of E-Box activity of the h-TERT promoter 173
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 165
The "Two-Faced" Effects of Reactive Oxygen Species and the Lipid Peroxidation Product 4-Hydroxynonenal in the Hallmarks of Cancer 156
4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity 153
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells. 150
Identification of 4-Hydroxynonenal-alpha-enolase adducts in HL-60 human leukemic cells: inhibition of plasminogen binding 146
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. 142
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network, in colon cancer cells 137
Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity 137
MicroRNA expression profiling during human leukemic HL-60 cell differentiation induced by 4-Hydroxynonenal, a product of lipid peroxidation 136
Rosiglitazone, Alone or in Combination with AS601245, an Anti-Inflammatory JNK Inhibitor, Affects Apoptosis, Differentiation and Cell Adhesion in CaCo-2 Human Colon Cancer Cells Through Modulation of Specific Gene Expressions. 134
Combined Antitumoral Efficacy of the Histone Deacetilase Inhibitor LBH589 and Lipids Peroxidation End Product 4-Hydroxinonenal(HNE)on PC3 Prostate Cancer Cell. 132
Targeting Cell Cycle Through Combination of the Histone Deacetylase Inhibitor, LBH589,and Lipids Peroxidation End Product,4-Hydroxnonenal (HNE), in PC3 Prostate Cancer Cells. 130
Increase of telomerase activity and hTERT expression in myelodysplastic syndromes 116
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migartion Trhougt modulation of specific Gene Expression in Human Colon Cancer Cells. 113
Combined antitumoral efficacy of the histone deacetilase inhibitor LBH589 and the lipid peroxidation end product 4-hydroxynonenal (HNE) on PC3 prostate cancer cell. 106
The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products 106
Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands inhibit telomerase activity and h-TERT expression in CaCo-2 colon cancer cells 102
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. 91
Totale 7.058
Categoria #
all - tutte 18.183
article - articoli 0
book - libri 0
conference - conferenze 7.605
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.788


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022315 0 0 0 18 6 9 18 12 11 34 131 76
2022/2023652 73 59 10 90 56 180 34 36 45 21 34 14
2023/2024440 37 62 25 35 32 49 38 48 1 35 38 40
2024/2025803 21 48 42 80 186 45 16 37 118 47 61 102
2025/20261.568 156 71 101 144 198 56 245 61 146 107 68 215
2026/2027374 82 106 102 84 0 0 0 0 0 0 0 0
Totale 7.058